TopoTarget - Deleted Q1 Target Price
2011-02-11 09:11, Edited at: 2011-02-11 09:11Please note: Community posts are written by its members and not by Redeye’s research department. As a reader you’re always encouraged to critically analyze the content.
In the recent analysis “TopoTarget - High Time to Double”, the target price was set to 7.5 DKr for the end of Q1 which was partly due to the belief that information regarding the ongoing PTCL study would be released. A few days ago, I submitted a question (through the Spectrum webpage) and received a rapid answer within a day, please read the respective e-mails below.
“dear Sir/Madam,
i would like to know whether Spectrum aims to publish interrim data for ptcl or not. perhaps an obvious question but as i havent found the information on your webpage im not sure that it has been explicitely expressed yet.
best regards
/Dr Linn Baal”
Response-mail
“Dr. Baal:
There are no interim analyses for the PTCL trial, therefore, there will not be publishing any interim data. The only data that will be published will be final data.
If you have any other questions, please do not hesitate to give me a call at 949-788-6700x216.
Sincerely,
Paul”
Based on the interpretation that Spectrum will not release any [new] information regarding this study in the nearest time, the probability that the strong trigger value associated with this particular study will have any influence on the share price within this time span is reduced significantly. Consequently, although it is possible that events in Q1 may imply trigger value, the current target price (7.5 DKr) is too speculative and is therefore deleted.
The target price of 14 DKr for the end of 2011 remains.
/
Dr Linn Baal